Skip to main content
Erschienen in: World Journal of Surgery 2/2020

11.09.2019 | Original Scientific Report

Biochemical Profile Affects IOPTH Kinetics and Cure Rate in Primary Hyperparathyroidism

verfasst von: Claire E. Graves, Catherine M. McManus, John A. Chabot, James A. Lee, Jennifer H. Kuo

Erschienen in: World Journal of Surgery | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Recently, normocalcemic (NC) and normohormonal (NH) variants of primary hyperparathyroidism (pHPT) have been described, with distinct biochemical profiles from the typical high serum calcium and parathyroid hormone (PTH) levels. Here, we investigate whether biochemical profile affects cure rate, as well as the kinetics of intraoperative PTH (IOPTH).

Methods

This is a single-center, retrospective study of pHPT patients undergoing parathyroidectomy. Patients were grouped based on preoperative calcium and PTH levels into typical, NC (normal calcium, elevated PTH, no evidence of secondary hyperparathyroidism), and NH (elevated calcium, unsuppressed PTH) biochemical profiles. All patients had IOPTH monitoring and ≥6-month post-op serum studies to confirm surgical cure. Patient variables were analyzed with Kruskal–Wallis test and Chi-square analysis. IOPTH kinetic curves were analyzed using a linear mixed model.

Results

From June 2006 to October 2014, 646 patients met inclusion criteria. Biochemical profile was typical in 460 patients (71%), NC in 101 (16%), and NH in 85 (13%). IOPTH levels were higher at all time points in typical patients, p < 0.001. Surgical cure rates were significantly lower for NC patients (90.1%) than for typical (98.5%) or NH patients (97.7%), p < 0.001, although a stricter criteria for cure was used in this group (normal calcium AND normal PTH). In a multivariable linear mixed model, NC patients had a significantly slower rate of IOPTH decline (p < 0.001 at 10 min).

Conclusions

Here, we better characterize the atypical variants of pHPT. Using a stricter definition of cure in the NC variant, these patients have a lower surgical cure rate than typical or NH variants in pHPT. The IOPTH curve is affected by biochemical profile, with both NC and NH patients having lower absolute values and NC patients having a slower decline.
Literatur
1.
Zurück zum Zitat Bandeira L, Bilezikian J (2016) Primary hyperparathyroidism. F1000Res 5CrossRef Bandeira L, Bilezikian J (2016) Primary hyperparathyroidism. F1000Res 5CrossRef
2.
Zurück zum Zitat Wilhelm SM, Wang TS, Ruan DT et al (2016) The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959–968CrossRef Wilhelm SM, Wang TS, Ruan DT et al (2016) The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959–968CrossRef
3.
Zurück zum Zitat Bilezikian JP, Cusano NE, Khan AA et al (2016) Primary hyperparathyroidism Nat Rev Dis Primers 2:16033CrossRef Bilezikian JP, Cusano NE, Khan AA et al (2016) Primary hyperparathyroidism Nat Rev Dis Primers 2:16033CrossRef
4.
Zurück zum Zitat Pasieka JL, Parsons L, Jones J (2009) The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery 146:1006–1013CrossRef Pasieka JL, Parsons L, Jones J (2009) The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery 146:1006–1013CrossRef
5.
Zurück zum Zitat Silverberg SJ, Clarke BL, Peacock M et al (2014) Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99:3580–3594CrossRef Silverberg SJ, Clarke BL, Peacock M et al (2014) Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99:3580–3594CrossRef
6.
Zurück zum Zitat Tassone F, Guarnieri A, Castellano E et al (2015) Parathyroidectomy Halts the deterioration of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab 100:3069–3073CrossRef Tassone F, Guarnieri A, Castellano E et al (2015) Parathyroidectomy Halts the deterioration of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab 100:3069–3073CrossRef
7.
Zurück zum Zitat Lundstam K, Heck A, Godang K et al (2017) Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study). J Bone Miner Res 32:1907–1914CrossRef Lundstam K, Heck A, Godang K et al (2017) Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study). J Bone Miner Res 32:1907–1914CrossRef
8.
Zurück zum Zitat Rao DS, Phillips ER, Divine GW et al (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422CrossRef Rao DS, Phillips ER, Divine GW et al (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422CrossRef
9.
Zurück zum Zitat Sheldon DG, Lee FT, Neil NJ, et al. (2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137:1022–1026 (discussion 1026–1028).CrossRef Sheldon DG, Lee FT, Neil NJ, et al. (2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137:1022–1026 (discussion 1026–1028).CrossRef
10.
Zurück zum Zitat Cheng SP, Lee JJ, Liu TP et al (2015) Quality of Life after surgery or surveillance for asymptomatic primary hyperparathyroidism: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 94:e931CrossRef Cheng SP, Lee JJ, Liu TP et al (2015) Quality of Life after surgery or surveillance for asymptomatic primary hyperparathyroidism: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 94:e931CrossRef
11.
Zurück zum Zitat Mather HG (1953) Hyperparathyroidism with normal serum calcium. Br Med J 2:424–425CrossRef Mather HG (1953) Hyperparathyroidism with normal serum calcium. Br Med J 2:424–425CrossRef
12.
Zurück zum Zitat Wills MR, Pak CY, Hammond WG et al (1969) Normocalcemic primary hyperparathyroidism. Am J Med 47:384–391CrossRef Wills MR, Pak CY, Hammond WG et al (1969) Normocalcemic primary hyperparathyroidism. Am J Med 47:384–391CrossRef
13.
Zurück zum Zitat Siperstein AE, Shen W, Chan AK, et al. (1992) Normocalcemic hyperparathyroidism. Biochemical and symptom profiles before and after surgery. Arch Surg 127:1156–1157 (discussion 1161–1153).CrossRef Siperstein AE, Shen W, Chan AK, et al. (1992) Normocalcemic hyperparathyroidism. Biochemical and symptom profiles before and after surgery. Arch Surg 127:1156–1157 (discussion 1161–1153).CrossRef
14.
Zurück zum Zitat Lavryk OA, Siperstein AE (2017) Use of calcium and parathyroid hormone nomogram to distinguish between atypical primary hyperparathyroidism and normal patients. World J Surg 41:122–128CrossRef Lavryk OA, Siperstein AE (2017) Use of calcium and parathyroid hormone nomogram to distinguish between atypical primary hyperparathyroidism and normal patients. World J Surg 41:122–128CrossRef
15.
Zurück zum Zitat Applewhite MK, White MG, Tseng J et al (2017) Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism. Surgery 161:62–69CrossRef Applewhite MK, White MG, Tseng J et al (2017) Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism. Surgery 161:62–69CrossRef
16.
Zurück zum Zitat Lim JY, Herman MC, Bubis L et al (2017) Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism. Surgery 161:70–77CrossRef Lim JY, Herman MC, Bubis L et al (2017) Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism. Surgery 161:70–77CrossRef
17.
Zurück zum Zitat Trinh G, Noureldine SI, Russell JO et al (2017) Characterizing the operative findings and utility of intraoperative parathyroid hormone (IOPTH) monitoring in patients with normal baseline IOPTH and normohormonal primary hyperparathyroidism. Surgery 161:78–86CrossRef Trinh G, Noureldine SI, Russell JO et al (2017) Characterizing the operative findings and utility of intraoperative parathyroid hormone (IOPTH) monitoring in patients with normal baseline IOPTH and normohormonal primary hyperparathyroidism. Surgery 161:78–86CrossRef
18.
Zurück zum Zitat Trinh G, Rettig E, Noureldine SI et al (2018) Surgical management of normocalcemic primary hyperparathyroidism and the impact of intraoperative parathyroid hormone testing on outcome. Otolaryngol Head Neck Surg 159:630–637CrossRef Trinh G, Rettig E, Noureldine SI et al (2018) Surgical management of normocalcemic primary hyperparathyroidism and the impact of intraoperative parathyroid hormone testing on outcome. Otolaryngol Head Neck Surg 159:630–637CrossRef
19.
Zurück zum Zitat Lee D, Walker MD, Chen HY et al (2019) Bone mineral density changes after parathyroidectomy are dependent on biochemical profile. Surgery 165:107–113CrossRef Lee D, Walker MD, Chen HY et al (2019) Bone mineral density changes after parathyroidectomy are dependent on biochemical profile. Surgery 165:107–113CrossRef
20.
Zurück zum Zitat Udelsman R, Akerstrom G, Biagini C et al (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99:3595–3606CrossRef Udelsman R, Akerstrom G, Biagini C et al (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99:3595–3606CrossRef
21.
Zurück zum Zitat Greene AB, Butler RS, McIntyre S et al (2009) National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg 209:332–343CrossRef Greene AB, Butler RS, McIntyre S et al (2009) National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg 209:332–343CrossRef
22.
Zurück zum Zitat Carneiro DM, Solorzano CC, Nader MC, et al. (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 134:973–979 (discussion 979–981).CrossRef Carneiro DM, Solorzano CC, Nader MC, et al. (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 134:973–979 (discussion 979–981).CrossRef
24.
Zurück zum Zitat Sokoll LJ, Drew H, Udelsman R (2000) Intraoperative parathyroid hormone analysis: A study of 200 consecutive cases. Clin Chem 46:1662–1668PubMed Sokoll LJ, Drew H, Udelsman R (2000) Intraoperative parathyroid hormone analysis: A study of 200 consecutive cases. Clin Chem 46:1662–1668PubMed
25.
Zurück zum Zitat Venkat R, Kouniavsky G, Tufano RP et al (2012) Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg 36:55–60CrossRef Venkat R, Kouniavsky G, Tufano RP et al (2012) Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg 36:55–60CrossRef
26.
Zurück zum Zitat Richards ML, Thompson GB, Farley DR et al (2011) An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg 146:280–285CrossRef Richards ML, Thompson GB, Farley DR et al (2011) An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg 146:280–285CrossRef
27.
Zurück zum Zitat Sho S, Kuo EJ, Chen AC et al (2019) Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism. Ann Surg Oncol 26:539–546CrossRef Sho S, Kuo EJ, Chen AC et al (2019) Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism. Ann Surg Oncol 26:539–546CrossRef
28.
Zurück zum Zitat Wade TJ, Yen TW, Amin AL et al (2012) Surgical management of normocalcemic primary hyperparathyroidism. World J Surg 36:761–766CrossRef Wade TJ, Yen TW, Amin AL et al (2012) Surgical management of normocalcemic primary hyperparathyroidism. World J Surg 36:761–766CrossRef
Metadaten
Titel
Biochemical Profile Affects IOPTH Kinetics and Cure Rate in Primary Hyperparathyroidism
verfasst von
Claire E. Graves
Catherine M. McManus
John A. Chabot
James A. Lee
Jennifer H. Kuo
Publikationsdatum
11.09.2019
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 2/2020
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05157-x

Weitere Artikel der Ausgabe 2/2020

World Journal of Surgery 2/2020 Zur Ausgabe

Presidential Address

Mastery in Endocrine Surgery

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.